Citadel Advisors - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$175,891
+16.3%
50,689
+55.8%
0.00%
Q2 2023$151,256
-90.1%
32,528
-90.2%
0.00%
Q1 2023$1,528,148
+51.2%
330,768
+164.4%
0.00%
Q4 2022$1,010,824
-39.7%
125,102
-58.6%
0.00%
Q3 2022$1,676,000
-50.4%
302,092
-53.4%
0.00%
-100.0%
Q2 2022$3,376,000
+14.8%
647,999
+81.1%
0.00%0.0%
Q1 2022$2,942,000
-66.9%
357,845
-40.0%
0.00%
-50.0%
Q4 2021$8,880,000
-29.8%
596,770
-10.9%
0.00%
-33.3%
Q3 2021$12,650,000
-12.0%
669,643
-13.4%
0.00%0.0%
Q2 2021$14,370,000
-37.5%
772,994
-23.5%
0.00%
-40.0%
Q1 2021$23,002,000
-18.1%
1,010,620
-21.8%
0.01%
-28.6%
Q4 2020$28,071,000
+128.9%
1,293,004
+6.0%
0.01%
+133.3%
Q3 2020$12,262,000
+24.3%
1,220,125
-4.0%
0.00%
-25.0%
Q2 2020$9,867,000
-37.6%
1,271,523
-17.9%
0.00%
-42.9%
Q1 2020$15,803,000
-16.9%
1,549,354
-10.4%
0.01%
-12.5%
Q4 2019$19,019,000
+21.0%
1,728,976
-0.0%
0.01%
+14.3%
Q3 2019$15,724,000
-20.1%
1,729,804
+0.1%
0.01%
-22.2%
Q2 2019$19,669,000
-0.1%
1,728,345
-0.0%
0.01%
-10.0%
Q1 2019$19,696,000
+26.3%
1,729,203
+0.0%
0.01%
+11.1%
Q4 2018$15,596,000
-40.5%
1,729,043
-1.1%
0.01%
-25.0%
Q3 2018$26,226,0001,748,4210.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders